Tenofovir disoproxil fumarate is a salt of an oral prodrug of Tenofovir. Tenofovir is a nucleoside monophosphate (nucleotide) analogue, a new class of agents, which has an in vitro antiviral activity against retroviruses and hepadnaviruses by inhibiting the reverse transcriptase enzyme hence, by DNA chain termination. Because Tenofovir was not well absorbed from the intestine, the prodrug, Tenofovir disoproxil, was developed to increase the bioavailability. The present study deals with the crystal structure of Tenofovir disoproxil which is a free base for Tenofovir disoproxil fumarate salt having the IUPAC name as bis({[(propan-2-yloxy)carbonyl]oxy}methyl) ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonate. To confirm the absolute configuration of the Tenofovir disoproxil (free base) crystallization experiments planned. Single crystals were developed from ethyl acetate solvent by slow evaporation method. The molecule crystallizes into orthorhombic with a non-centrosymmetric space group of P212121 having the cell parameters of a=8.6960(3) Å, b=12.2660(5) Å, c= 23.8530(9) Å. The molecule has strong inter and intra molecular hydrogen bonding which makes the molecule to remain intact. The intra molecular hydrogen bonding between O4….…O6 leads to the formation cyclic five membered ring i.e., R11 (5) 
